Literature DB >> 6475486

Neuropathy and motor neuron syndromes associated with plasma cell disease.

B M Patten.   

Abstract

Increasing numbers of patients are being recognized with neurological abnormalities associated with the immunochemical changes of plasma cell disease. To illustrate the wide spectrum of clinical disorders that can be found, I discuss in detail 5 patients: 2 with neuropathy, 3 with amyotrophic lateral sclerosis (ALS), all of whom had serum monoclonal paraproteinemia. In addition, I report in tabular form 6 patients with paraproteinemia and the following clinical presentations: 1) systemic lupus with polyneuropathy and severe cerebritis, 2) myasthenia gravis with thymoma, 3) polymyositis, 4) polymyositis, arthritis and Grave's disease, 5) relapsing polyneuritis (one of the original patients diagnosed by Austin) and 6) ALS, dystonia and parkinsonism. Major improvements in clinical condition occurred sometimes, but not always, coincident with reductions in the levels of the paraprotein using prednisone, cyclophosphamide, chlorambucil and plasma exchange treatments even in some of the patients who had the clinical appearance of ALS. Patients with neuromuscular diseases should be routinely screened with serum immunoelectrophoresis for monoclonal gammopathy. If a monoclonal gammopathy is found and if the disease is serious, then those patients should be treated as if they had an autoimmune disorder.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6475486     DOI: 10.1111/j.1600-0404.1984.tb00802.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  Amyotrophic lateral sclerosis-motor neuron disease, monoclonal gammopathy, hyperparathyroidism, and B12 deficiency: case report and review of the literature.

Authors:  Richard A Rison; Said R Beydoun
Journal:  J Med Case Rep       Date:  2010-09-01

2.  Current Therapies for Paraneoplastic Neurologic Syndromes.

Authors:  Myrna R. Rosenfeld; Josep Dalmau
Journal:  Curr Treat Options Neurol       Date:  2003-01       Impact factor: 3.598

Review 3.  Amyotrophic lateral sclerosis with laboratory abnormalities of uncertain significance: A brief review.

Authors:  Majid Ghasemi; Farzad Fatehi; Bahador Asadi; Fariborz Khorvash
Journal:  Iran J Neurol       Date:  2012
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.